PCEssentials Hormone Therapy Study
If you have prostate cancer and your doctor has recommended androgen deprivation therapy or hormone therapy, the Prostate Cancer Foundation of Australia (PCFA) would like to invite you to take part in a research study.
What is involved?
The participants of this study will receive one of two types of support.
- Support from a nurse, during four telehealth sessions over three months, and a final session at six months.
- A package of resources containing:
- information about androgen deprivation therapy or hormone therapy to treat prostate cancer
- advice about referral to support services
All participants will be followed up by the study team at three, six and 12 months after they join the study.
This study will run from November 2022 to December 2024.
If you would like to participate or receive more information about the study, please contact the PCEssentials Hormone Therapy study team directly.
02 9438 7060